Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)

NCT04280536 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT04280536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04280536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)
Lead sponsor
National University Hospital, Singapore
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
August 14, 2019
Completion date
June 30, 2026
Enrollment
86 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer